Predictors of outcome in XXXX with @entity5426 .

@entity417 @entity882 @entity235 @entity5 @entity5426 @entity3 @entity4795
OBJECTIVE: To identify prognostic factors in a large group of @entity235 with @entity5426 ( @entity5426 ) or both. Design-Multi-institutional retrospective cohort study. Animals-71 @entity235 with subcutaneous or intramuscular @entity5426 . PROCEDURES: Medical records of affected @entity235 were reviewed. The following factors were evaluated for an association with outcome: @entity235 age and sex, clinical signs, @entity417 , @entity882 , @entity4795 , @entity5 stage at diagnosis, achievement of complete excision, intramuscular involvement, presence of gross disease, @entity5 recurrence, and treatment. RESULTS: Of the 71 cases identified, 16 (29%) had intramuscular @entity5 involvement. For all @entity235 , median time to @entity5 progression and overall survival time (OST) were 116 and 172 days, respectively; 25% survived to 1 year. Univariate analysis identified presence of clinical signs or @entity3 at diagnosis, @entity235 age, @entity5 size, use of any surgery, and presence of gross disease as predictors of time to @entity5 progression and OST. There was no significant difference in survival time between @entity235 with respect to type of @entity5426 . Multivariate analysis confirmed that adequate @entity5 control, @entity5 diameter  <= 4 cm, presence of @entity3 at diagnosis, and presence of gross disease were significantly associated with OST. CONCLUSIONS AND CLINICAL RELEVANCE: Subcutaneous and intramuscular @entity5426 remains a heterogeneous group of @entity5 that generally carries a poor prognosis. Adequate local control of @entity5 with no associated clinical signs or @entity3 may provide the best chance of long-term survival.
